Lecture 15 Flashcards
Give two reasons why gene regulation is more complicated in eukaryotes as compared to bacteria.
-typically encode more transcription factors than bacteria
-regulatory sequences can be in the “long range” rather than just in the promoter
-alteration of chromatin states is a mechanism of gene regulation in eukaryotes
What two types of regulation are present within multicellular eukaryotes that are not resent in
bacteria? Explain what is meant by each.
- temporal regulations: certain genes are turned on during different checkpoints of development
- Spatial: turning on/off certain genes in specific tissue
Compare and contrast the characteristics of the core promoter with that of an enhancer sequence.
How are they similar and how are they different?
The core promoter binds generalized transcription factors and must be upstream of a gene
Silencers and enhancers however promote or prevent transcription via the interaction of proteins with the core promoter, they can be located anywhere in the gene.
Can provide on/off regulation and dimmer regulation.
Explain how different patterns of SHH expression are accomplished in the brain and in the limbs.
SHH gene has a LONG RANGE enhancer to promote gene expression in the limbs and a closer enhancer to promote gene expression in the brain .
In the limb there are no specific brain transcription factors we express SHH in the limb specific way, vice verse for expressing brain specric patter of SHH.
Propose a plausible outcome for using CRISPR to replace the cobra SHH enhancer with the
mouse SHH enhancer within a cobra.
this will results in the cobra having an SHH enhancer that upregulated limb development so when the SHH is activated forto allow for transcription it is likely that limb development in cobras would occur
Summarize the general argument for why morphological evolution is presumed to more often be
driven by regulatory rather than coding changes. Illustrate this argument using the example of
humans and chimps.
human and chimps have 99% commonalities of AAs however we have vastly different morphological attributes due to there being
different AMOUNTS of proteins being turned on at different TIMES, in different TISSUES
A mutation in the beta-globin LCR causes Thalassemia. Propose a plausible mechanism of action
of this mutation.
A locus control region controls many different genes and said genes enhacer proteins, however each gene produces its on mrna as opposed to polycistronic mrna.
mutation to the beta-globin LCR changes the 1:1 stoichiometry of alpha and beta globin, not lethal due to modularity but still has an effect caus thalssemia.
fetus have different globins to steal oxygen from the mothers blood
Define modularity in the context of enhancers and silencers. Suppose that enhancers were not
modular, how would this change the consequences of mutations in these in these regions?
modularity is present in enhancers and silencers because if a protein can’t bind to specific enhance or silencers that will not affect how other silencers or enhancers in the gene bind.
If enhancers were not modular, the natural section would select against mutations to these enhancer sequences, leading to species that are very diverged evolutionarily having the same sequences.
Why are some non-coding enhancer elements so highly conserved?
natural selection selects agains enhancer regions ever having LOF mutations as this individual will likely die due to gene expression being completely down-regulated when it shouldn’t
How can the property of modularity give rise to different species using different binding sites and
different trans-acting proteins to regulate a gene, but the pattern of gene expression remains similar
between these species?
Binding site turnover results in enhancer modules differing across species due to a mutation in the binding site causing the binding site to be in the same location but changing the protein which binds.
THis results in the enhancer sequences across species using different binding sites and proteins but having the same out put which preserves modularity as there are different inputs but the same gene expression across species.
Explain the mechanism of activation of the Gal genes in yeast. Your answer should explain the
roles of UASG Gal80, Gal4, and Gal3 both in the presence and in the absence of galactose
For galactose use in the body you need gal 4 to bind UpstreamActivatorSequence which is the enhancer sequence.
In the absence of galactose:
gal4 binds gal 80 instead of UAS preventing the 4 genes necessary for galactose utilization to be expressed.
Gal 3 is within the cytoplasm.
In the presence of galactose:
gal 3 will migrate to the nucleus and bind gal 80.
this will release gal 4 from gal 80 allowing it to bind the UAS and activate the necessary genes.
Explain the mechanism of repression of the Gal pathway in yeast. Your answer should explain the
roles/location if Mig1 both in the presence and absence of glucose.
Instead of there being an inducer as seen in bacteria w/ lac operon you have silencers.
When glucose is present(preferred carbon source over galactose)
MIg1 will bind a silencer between UAS and Gal genes to prevent activation of gal pathway
When glucose is absent :
enzyme phosphorylates MIG1 –> exported from nucleus so it does not obscure UAS
Compare and contrast the gal pathway with the lac operon. How are they similar and how are
they different?
How are enhancers directed to only act to increase the transcription of specific target genes?
insulator blocks communication between enhancers and non-target promoters and will allow enhancers nearby the promoter that are not blocked by the insulator to be activated
What is position effect variegation? Are these mutations altering coding sequence? Explain
A structural mutation moved the gene that controlled the drosophilas eye’s pigment to a heterochromatic region. The mutation are not altering coding sequence they epigenetic and are affect expression of the gene based on how wrapped the DNA is around the histone in that region